32% lower risk of death†
*Hormone therapy includes drug treatments to lower testosterone or surgery.
‡Median is the middle value in a set of numbers, not the average.
men lived 2x longer without cancer spreading (median‡ 3.4 yrs vs 1.5 yrs)
In the same study, looking at overall survival (OS) men had a 31% lower risk of death
§The clinical study in nmCRPC was designed to measure metastasis-free survival (MFS) and also overall survival.
How do you pronounce NUBEQA?
(new-BECCA)
Press to hear pronunciation
Caregivers: Thanks for Being Here
You have access to helpful tips and resources created just for you.
Frequently Asked Questions
It's natural to have questions, so we have the answers all in one place.
NUBEQA Patient Brochure
Find out more about NUBEQA and what it means for your type of prostate cancer.
Patient Stories
You are not alone. See the stories of men taking NUBEQA and what their caregivers have to say.
Dr. Tom Green’s Story
Learn more about Dr. Green, a urologist and NUBEQA patient himself, as he talks about navigating diagnosis and treatment.
Dick and Jan’s Story
See how NUBEQA patient Dick navigates life after diagnosis as he continues to pursue his passions with the support of his loving wife, Jan.